(Q24673003)

English

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil" (English)

0 references

X-linked adrenoleukodystrophy

1 reference

based on heuristic

inferred from title

author name string

B M van Geel

1

0 references

J Assies

2

0 references

E B Haverkort

3

0 references

J H Koelman

4

0 references

B Verbeeten

5

0 references

R J Wanders

6

0 references

P G Barth

7

0 references

language of work or name

0 references

publication date

September 1999

0 references

Journal of Neurology, Neurosurgery and Psychiatry

0 references

67

0 references

3

0 references

290-9

0 references

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

7 April 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

7 April 2017

Lorenzo's oil and platelet activation in adrenomyeloneuropathy and asymptomatic X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

A mouse model for X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Dietary management of X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

The Barthel ADL Index: a standard measure of physical disability?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Adrenoleukodystrophy: phenotypic variability and implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 September 2017

Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

High dose immunoglobulin IV treatment in adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

30 May 2018

A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

19 June 2018

In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Somatosensory evoked potentials, sensory nerve potentials and sensory nerve conduction in hereditary motor and sensory neuropathy type I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736534

28 November 2018

Progression of X-linked adrenoleukodystrophy under interferon-beta therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced stimulability of platelet surface adhesion molecules under treatment with Lorenzo's oil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posterior tibial and sural nerve somatosensory evoked potentials: a study in spastic paraparesis and spinal cord lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Synthesis of Hexacosanoic Acid (C26 :0) by Cultured Skin Fibroblasts from Patients with Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN)1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lorenzo's oil and lymphocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin for X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10449548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.67.3.290

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24673003&oldid=1951347125"